XTLB Stock Summary and Trading Ideas (XTL Biopharmaceuticals Ltd. - American Depositary Shares | NASDAQ:XTLB)

XTL Biopharmaceuticals Ltd is an intellectual property-based company focused on the development, management, and commercialization of intellectual property. The Company is engaged in biotechnology through its subsidiary Psyga Bio and in the biopharmaceutical industry with hCDR1, a novel compound working via a novel mechanism of action for the treatment of Systemic Lupus Erythematosus (SLE) and a potential treatment for Sjogren's syndrome (SS). It focuses on the acquisition and development of proprietary products and late-stage pharmaceutical product candidates for the treatment of unmet clinical needs.

XTL Biopharmaceuticals Ltd. - American Depositary Shares trades on the NASDAQ stock market under the symbol XTLB.

As of September 10, 2026, XTLB stock price was flat at $2.52 with 97 million shares trading.

XTLB has a beta of 1.03, meaning it tends to be more sensitive to market movements. XTLB has a correlation of 0.02 to the broad based SPY ETF.

XTLB has a market cap of $6.19 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, XTLB traded as high as $19.96 and as low as $2.01.

XTLB has underperformed the market in the last year with a price return of -58.0% while the SPY ETF gained +17.7%. However, in the short term, XTLB had mixed performance relative to the market. It has outperformed in the last 3 months, returning +8.6% vs +3.1% return in SPY. But in the last 2 weeks, XTLB shares have been beat by the market, returning -2.3% compared to an SPY return of -1.1%.

XTLB support price is $2.28 and resistance is $2.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XTLB shares will trade within this expected range on the day.